These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30447712)

  • 21. Medical and surgical therapy of hypertrophic cardiomyopathy.
    Bonow RO; Maron BJ; Leon MB; Cannon RO; Epstein SE
    Cardiovasc Clin; 1988; 19(1):221-39. PubMed ID: 2901911
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hypertrophic cardiomyopathy (clinical aspects, diagnosis and treatment)].
    Paleev NR; Gurevich MA; Odinokova VA; Iankovskaia MO; Smirnov VB
    Kardiologiia; 1990 Nov; 30(11):7-13. PubMed ID: 1982327
    [No Abstract]   [Full Text] [Related]  

  • 23. Septal myectomy results in regression of left ventricular hypertrophy in patients with hypertrophic obstructive cardiomyopathy.
    Deb SJ; Schaff HV; Dearani JA; Nishimura RA; Ommen SR
    Ann Thorac Surg; 2004 Dec; 78(6):2118-22. PubMed ID: 15561048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recognition and treatment of left ventricular diastolic dysfunction.
    Stauffer JC; Gaasch WH
    Prog Cardiovasc Dis; 1990; 32(5):319-32. PubMed ID: 1969174
    [No Abstract]   [Full Text] [Related]  

  • 25. Evidence for or against the efficacy of calcium channel blockers for management of hypertrophic cardiomyopathy in cats.
    Bright JM; Golden AL
    Vet Clin North Am Small Anim Pract; 1991 Sep; 21(5):1023-34. PubMed ID: 1683045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
    Korovina EP
    Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Verapamil in the treatment of hypertrophic cardiomyopathy.
    Rosing DR; Epstein SE
    Ann Intern Med; 1982 May; 96(5):670-2. PubMed ID: 6122414
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hypertensive hypertrophic cardiomyopathy in older patients].
    Schuster P; Sturm A
    Dtsch Med Wochenschr; 1985 Nov; 110(44):1714-5. PubMed ID: 2865119
    [No Abstract]   [Full Text] [Related]  

  • 29. Calcium antagonist agents in hypertrophic cardiomyopathy.
    Chatterjee K
    Am J Cardiol; 1987 Jan; 59(3):146B-152B. PubMed ID: 3812266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understand your treatment options if you have HOCM. New devices and procedures are available to help manage hypertrophic obstructive cardiomyopathy.
    Heart Advis; 2010 Feb; 13(2):3. PubMed ID: 21192383
    [No Abstract]   [Full Text] [Related]  

  • 31. [Combination therapy of beta blockers for heart failure].
    Watanabe M; Hirata Y
    Nihon Rinsho; 2007 May; 65 Suppl 5():129-33. PubMed ID: 17571376
    [No Abstract]   [Full Text] [Related]  

  • 32. Late sodium current inhibitors to treat exercise-induced obstruction in hypertrophic cardiomyopathy: an in vitro study in human myocardium.
    Ferrantini C; Pioner JM; Mazzoni L; Gentile F; Tosi B; Rossi A; Belardinelli L; Tesi C; Palandri C; Matucci R; Cerbai E; Olivotto I; Poggesi C; Mugelli A; Coppini R
    Br J Pharmacol; 2018 Jul; 175(13):2635-2652. PubMed ID: 29579779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hypertrophic cardiomyopathy: place and limitations of medical therapy].
    Desnos M; Hagège A; Guérot C
    Arch Mal Coeur Vaiss; 1995 Apr; 88(4 Suppl):573-5. PubMed ID: 7487302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pushing the Limits of Medical Management in HCM: A Review of Current Pharmacological Therapy Options.
    Stătescu C; Enachi Ș; Ureche C; Țăpoi L; Anghel L; Șalaru D; Pleșoianu C; Bostan M; Marcu D; Ovanez Balasanian M; Sascău RA
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small Molecules acting on Myofilaments as Treatments for Heart and Skeletal Muscle Diseases.
    Alsulami K; Marston S
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33339418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacotherapy for the treatment of obstructive hypertrophic cardiomyopathy.
    Spoladore R; Fragasso G; Pannone L; Slavich M; Margonato A
    Expert Opin Pharmacother; 2020 Feb; 21(2):233-242. PubMed ID: 31893930
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of hypertrophic cardiomyopathy in children.
    Seggewiss H; Rigopoulos A
    Paediatr Drugs; 2003; 5(10):663-72. PubMed ID: 14510624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mavacamten: A Novel Disease-Specific Treatment for Hypertrophic Cardiomyopathy.
    Capilupi MJ; Frishman WH
    Cardiol Rev; 2023 Jan-Feb 01; 31(1):45-51. PubMed ID: 35358098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term survival in patients with resting obstructive hypertrophic cardiomyopathy comparison of conservative versus invasive treatment.
    Ball W; Ivanov J; Rakowski H; Wigle ED; Linghorne M; Ralph-Edwards A; Williams WG; Schwartz L; Guttman A; Woo A
    J Am Coll Cardiol; 2011 Nov; 58(22):2313-21. PubMed ID: 22093509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertrophic cardiomyopathy.
    Landmark K
    Acta Pharmacol Toxicol (Copenh); 1986; 58 Suppl 2():169-74. PubMed ID: 2424266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.